Lundbeck
HLUN-B.CO
#2700
Rank
NZ$11.43 B
Marketcap
NZ$11.53
Share price
-1.65%
Change (1 day)
24.27%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): NZ$1.03

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.08. an increase over its 2024 EPS that were of NZ$0.78.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ$0.8914.5%
2024NZ$0.7829.29%
2023NZ$0.6023.09%
2022NZ$0.4937.26%
2021NZ$0.36-84.61%
2020NZ$2.31-24.61%
2019NZ$3.06-42.06%
2018NZ$5.2940.7%
2017NZ$3.76146.26%
2016NZ$1.53-120.48%
2015NZ-$7.453231.32%
2014NZ-$0.22-115.78%
2013NZ$1.42-23.36%
2012NZ$1.85-48.01%
2011NZ$3.56-9.68%
2010NZ$3.9413.72%
2009NZ$3.4624.32%
2008NZ$2.78-6.05%
2007NZ$2.9681.77%
2006NZ$1.63-16.76%
2005NZ$1.96-17.58%
2004NZ$2.38